EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular mechanisms on how FABP5 inhibitors promote apoptosis‐induction sensitivity of prostate cancer cells

Jiacheng Zhang, Gang He, Xi Jin, Bandar T Alenezi, Abdulghani A Naeem, Saud A Abdulsamad, Youqiang Ke

Cell Biology International · 2023-05 · 47 (5) · 929-942

DOI: 10.1002/cbin.11989 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biology International, online erschienen am 18.01.2023. Verfasst von Jiacheng Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Clinical Cancer Medicine, Liverpool University, Liverpool, UK. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Prostatic Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous work showed that FABP5 inhibitors suppressed the malignant progression of prostate cancer cells, and this suppression might be achieved partially by promoting apoptosis. But the mechanisms involved were not known. Here, we investigated the effect of inhibitors on apoptosis and studied the relevant mechanisms. WtrFABP5 significantly reduced apoptotic cells in 22Rv1 and PC3 by 18% and 42%, respectively. In contrast, the chemical inhibitor SB‐FI‐26 produced significant increases in percentages of apoptotic cells in 22Rv1 and PC3 by 18.8% (±4.1) and 4.6% (±1.1), respectively. The bio‐ inhibitor dmrFABP5 also did so by 23.1% (±2.4) and 15.8% (±3.0), respectively, in these cell lines. Both FABP5 inhibitors significantly reduced the levels of the phosphorylated nuclear fatty acid receptor PPARγ, indicating that these inhibitors promoted apoptosis‐induction sensitivity of the cancer cells by suppressing the biological activity of PPARγ. Thus, the phosphorylated PPARγ levels were reduced by FABP5 inhibitors, the levels of the phosphorylated AKT and activated nuclear factor kapper B (NFκB) were coordinately altered by additions of the inhibitors. These changes eventually led to the increased levels of cleaved caspase‐9 and cleaved caspase‐3; and thus, increase in the percentage of cells undergoing apoptosis. In untreated prostate cancer cells, increased FABP5 suppressed the apoptosis by increasing the biological activity of PPARγ, which, in turn, led to a reduced apoptosis by interfering with the AKT or NFκB signaling pathway. Our results suggested that the FABP5 inhibitors enhanced the apoptosis‐induction of prostate cancer cells by reversing the biological effect of FABP5 and its related pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktProstatic NeoplasmsMaleHumansPPAR gammaCell Line, TumorApoptosisFatty Acid-Binding Proteins

Stichwörter der Autor:innen

AB-FI-26FABP5PPARүapoptosisdmrFABP5prostate cancer

Substanzen

Proto-Oncogene Proteins c-aktPPAR gammaFatty Acid-Binding ProteinsFABP5 protein, human

Autor:innen und Institutionen

  • Department of Molecular and Clinical Cancer Medicine, Liverpool University, Liverpool, UK.
  • Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu, Sichuan, China.
  • Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Zitieren

APA

Zhang, J., He, G., Jin, X., Alenezi, B. T., Naeem, A. A., Abdulsamad, S. A., & Ke, Y. (2023). Molecular mechanisms on how FABP5 inhibitors promote apoptosis‐induction sensitivity of prostate cancer cells. Cell Biology International, 47(5), 929-942. https://doi.org/10.1002/cbin.11989

Vancouver

Zhang J, He G, Jin X, Alenezi BT, Naeem AA, Abdulsamad SA, et al. Molecular mechanisms on how FABP5 inhibitors promote apoptosis‐induction sensitivity of prostate cancer cells. Cell Biology International. 2023;47(5):929-942. doi:10.1002/cbin.11989

BibTeX
@article{Zhang2023,
  author = {Zhang, Jiacheng and He, Gang and Jin, Xi and Alenezi, Bandar T and Naeem, Abdulghani A and Abdulsamad, Saud A and Ke, Youqiang},
  title = {Molecular mechanisms on how FABP5 inhibitors promote apoptosis‐induction sensitivity of prostate cancer cells},
  journal = {Cell Biology International},
  year = {2023},
  volume = {47},
  number = {5},
  pages = {929--942},
  doi = {10.1002/cbin.11989}
}
Kostenlos starten →